Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
Novo Nordisk CEO Grilled by Congress Over Price of Ozempic
WEDNESDAY, Sept. 25, 2024 – During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company's high prices for its ...
Semaglutide May Lower Risk for Opioid Overdose in T2DM, Opioid Use Disorder
WEDNESDAY, Sept. 25, 2024 – For patients with type 2 diabetes (T2D) and opioid use disorder (OUD), semaglutide is associated with a significantly lower risk for opioid overdose compared with other...
Four in Every 10 U.S. Adults Is Now Obese; Severe Obesity Rising
TUESDAY, Sept. 24, 2024 – Over 40 percent of U.S. adults are now obese, with rates roughly the same for men and women, new government data shows. Obesity rates fluctuated with age and fell as levels...
Diabetes Treatment Might Ease Gum Disease, Too
MONDAY, Sept. 23, 2024 – Diabetes can worsen the state of your gums, but a new study suggests that diabetes medications may undo some of that damage. Researchers in Japan found a positive turnaround...
SGLT2i Use Linked to Lower Risk for Neurodegenerative Disease in T2DM
WEDNESDAY, Sept. 18, 2024 – For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced risks for incident dementia and Parkinson disease...
Diabetes Complications Tied to Higher Risk for Gum Disease
THURSDAY, Sept. 19, 2024 – Neuropathy and retinopathy are positively associated with moderate/severe periodontitis, according to a study published online Aug. 5 in the Journal of Dental Research....
Metformin Use Tied to Lower Incidence of Death, Long COVID After COVID-19
THURSDAY, Sept. 19, 2024 – After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute...
GLP-1 RA Use Linked to Reduced Cirrhosis Risk in MASLD, Diabetes
TUESDAY, Sept. 17, 2024 – For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with...
Personality Tied to Cardiovascular Disease Risk With Type 2 Diabetes
TUESDAY, Sept. 17, 2024 – Personality traits can influence cardiovascular disease (CVD) risk with type 2 diabetes mellitus (T2DM), according to a study published online Sept. 10 in BMJ Open Diabetes ...
Ozempic Could Curb Progression of Diabetes-Linked Liver Disease
MONDAY, Sept. 16, 2024 – Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In...
Time-Restricted Eating Helps to Improve Diabetes Outcomes
FRIDAY, Sept. 13, 2024 – Time-restricted eating (TRE) may improve diabetes outcomes, independent of energy intake, according to a study presented at the annual meeting of the European Association...
Once-Weekly Efsitora Noninferior to Degludec for Type 2 Diabetes
FRIDAY, Sept. 13, 2024 – Once-weekly efsitora is noninferior to once-daily degludec for reducing glycated hemoglobin levels in adults with type 2 diabetes who have not received insulin, according to...
Weight Reduction Varies for Patients Receiving Semaglutide, Liraglutide
FRIDAY, Sept. 13, 2024 – For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent, dosage, treatment indication, and...
Exposure to Glucocorticoids Increases Risk for New-Onset Diabetes
WEDNESDAY, Sept. 11, 2024 – Exposure to systemic glucocorticoids during hospitalization is associated with an increased risk for new-onset diabetes, according to a study presented at the annual of...
Risk for T2D Increased for Individuals With Late Chronotype
WEDNESDAY, Sept. 11, 2024 – People with a late chronotype have an increased risk for type 2 diabetes (T2D) and have higher body mass index (BMI) and larger waist circumference, according to a study...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Lantus, Mounjaro, Trulicity, glipizide, semaglutide, Rybelsus, view more... Humalog, Farxiga, Lantus Solostar, Jardiance, Novolog, Janumet, insulin glargine, Januvia, insulin lispro, Bydureon, Tresiba, liraglutide, Levemir, Glucophage, Invokana, insulin degludec, Humulin N